February 25, 2018 11:54 AM ET

Health Care Technology

Company Overview of UltraSPECT Ltd.

Company Overview

UltraSPECT Ltd. provides nuclear medicine imaging reconstruction products that enhance the performance of nuclear medicine gamma cameras and PET scanners. The company offers Xpress.Cardiac for half-time and half-dose cardiac imaging; Xpress3.Cardiac, a three-minute myocardial perfusion SPECT; and Xpress/Xact.Bone for image quality and diagnostic certainty. It serves hospitals and clinics, as well as NM imaging centers in the United States, Europe, Asia, and Australia. UltraSPECT Ltd. was formerly known as UCG Technologies Ltd. The company was founded in 1999 and is based in Raanana, Israel with an additional office in Auburndale, Massachusetts.

Beit Bonei Binyan

2a Hamelacha Street

3rd Floor

P.O. Box 4184

Raanana,  4365704

Israel

Founded in 1999

Phone:

972 9 832 6222

Fax:

972 9 832 6222

Key Executives for UltraSPECT Ltd.

Chief Executive Officer and President
Co-Founder
Age: 62
Director of R&D
Compensation as of Fiscal Year 2017.

UltraSPECT Ltd. Key Developments

RWJPE Leverages UltraSPECT Low-Dose Imaging Technology at 4 Locations

UltraSPECT reported that Robert Wood Johnson Physician Enterprise (RWJPE), a multi-specialty, community-based physician group in Central New Jersey, implemented UltraSPECT's Xpress3.Cardiac solution at four of their sites: Cardiology Associates of New Brunswick in New Brunswick, NJ; Heart Specialists of Edison in Edison, NJ; and New Brunswick Cardiology Group in their offices in Somerset, NJ and Monroe, NJ. The software will benefit patient safety by reducing the dosage of injected radiopharmaceuticals, while lowering the radiation exposure for patients and nuclear staff alike. In addition, the technology saves valuable time for patients and staff, as it can produce the same high-quality SPECT images in less time than is typically required during standard exams. Torres also notes that the radiation exposure numbers on staff's monthly dosimetry reports have been steadily going down after the UltraSPECT implementation. This is due to both reduced scan time and reduced doses needed for imaging tests. All four installations are part of RWJPE's radiopharmaceutical supply agreement with Nuclear Diagnostic Products (NDP). NDP delivers diagnostic and therapeutic radiopharmaceuticals to its customers and offers UltraSPECT products to facilities looking for a solution to achieve faster and safer imaging while enhancing their diagnostic capabilities.

Similar Private Companies By Industry

Company Name Region
Academia Medica Middle East/Africa
ADHD Solutions, Ltd. Middle East/Africa
Aidoc LTD Middle East/Africa
Augmedics LTD Middle East/Africa
BioGaming Lts. Middle East/Africa

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
NYC2012, Inc. United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact UltraSPECT Ltd., please visit ultraspect.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.